Synthesis and anticancer evaluations of novel 1H-imidazole [4,5-f][1,10] phenanthroline derivative for the treatment of colorectal cancer.
1H-imidazole [4,5-f][1,10] phenanthroline
Apoptosis
Cell cycle
Colorectal cancer
mTOR
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
05 Aug 2022
05 Aug 2022
Historique:
received:
20
11
2021
revised:
17
06
2022
accepted:
21
06
2022
pubmed:
27
6
2022
medline:
14
7
2022
entrez:
26
6
2022
Statut:
ppublish
Résumé
1H-imidazole [4,5-f][1,10] phenanthroline is a promising chemical structure for cancer treatment. Herein, we synthesized a novel 1H-imidazole [4,5-f][1,10] phenanthroline derivative named IPM714 and found it exhibited selectively colorectal cancer (CRC) cells inhibitory activities, with half maximal inhibitory concentration (IC
Identifiants
pubmed: 35753402
pii: S0014-2999(22)00381-8
doi: 10.1016/j.ejphar.2022.175120
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Imidazoles
0
Phenanthrolines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175120Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.